Abstract:Objective To investigate the expressions of topoisomeraseⅡ(ToPoⅡ) and multidrug resistance-associated protein (MRP) in human esophageal squamous cell carcinoma and their clinical significances. Methods The expressions of ToPoⅡ and MRP in 69 patients with esophageal squamous cell carcinoma were detected by immunohistochemical method, and their correlations with clinical pathological features were analyzed at the same time. Results The expression rate of ToPoⅡ reached to 94.2% (65/69), in which 47.8% (31/65) was moderately positive, and MRP was 63.8% (44/69). The expressions of ToPoⅡ and MRP were positively related (r=0.311, P0.01). Meanwhile, no significant correlations were found between the expression levels of ToPoⅡ and MRP and clinical pathological features including age, tumor location, lymph node metastases and TNM stage (all P0.05). Conclusion Detecting the expressions of ToPoⅡ and MRP can help to predict the sensitivity of tumor to chemotherapy drugs, personalize the therapeutic regimens and therefore improve the curative effect.

Expressions and Significances of Topoisomeraseⅱ and Multidrug Resistance-Associated Protein in Human Esophageal Squamous Cell Carcinoma